Dianthus Therapeutics, Inc.

DNTH ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
CORRESP Oct 7, 2024
CORRESP Oct 7, 2024
UPLOAD Oct 7, 2024
UPLOAD Oct 7, 2024
4 Oct 1, 2024 OWNERSHIP DOCUMENT
S-3 Oct 1, 2024 S-3
S-3 Oct 1, 2024 S-3
4 Sep 18, 2024 4
3 Sep 18, 2024 3
424B3 Sep 16, 2024 424B3
8-K Sep 16, 2024 8-K
SC 13D/A Sep 12, 2024 SC 13D/A
S-8 Aug 8, 2024 S-8
424B3 Aug 8, 2024 424B3
10-Q Aug 8, 2024 10-Q
8-K Aug 8, 2024 8-K
8-K Jun 6, 2024 8-K
4 May 28, 2024 4
4 May 28, 2024 4
4 May 28, 2024 4
4 May 28, 2024 4
4 May 28, 2024 4
4 May 28, 2024 4
4 May 28, 2024 4
4 May 28, 2024 4
← Newer Page 8 of 27 · 660 filings Older →